Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-06

The present notice is for the conclusion of agreements with pharmaceutical companies as per § 130a, para 8, sentence 1 SGB V. The invitation to participate is directed only to pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs as per § 4, para 18 of the Medicinal Products Act. This is not an Open Procedure as per § 15 VgV in conjunction with § 119, para 3 GWB, but a publication of the invitation to conclude/join rebate agreements with conditions fixed and non-negotiable for all participants, including the level of the rebate. Contract partners can be an unlimited number of pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs as per § 4, para 18 of the Medicinal Products Act.